It is too early to know what the long-term consequences of the coronavirus crisis will be for public attitudes toward expertise. While one imagines that the faster-than-expected development of vaccines will boost the prestige of pharmaceutical scientists, it is harder to predict how attitudes toward government organizations like the Centers for Disease Control and Prevention might change. At the moment, trust is not
We’re sorry. Something went wrong.
We are unable to fully display the content of this page.
The most likely cause of this is a content blocker on your computer or network. Please make sure your computer, VPN, or network allows javascript and allows content to be delivered from c950.chronicle.com and chronicle.blueconic.net.
Once javascript and access to those URLs are allowed, please refresh this page. You may then be asked to log in or create an account if you don't already have one.
If you continue to experience issues, contact us at 202-466-1032 or help@chronicle.com